HBOT Conversations Ep 2.6 | Dr. Hemal Mehta & Regenerative Medicine (Part 3)

In this segment with Dr. Hemal V. Mehta, MD, the Medical Director of Vibrant Health of North Carolina, the discussion delves into various aspects of regenerative medicine and its applications for different medical conditions. Here are the key points covered:

Cardiac Health: Dr. Mehta's clinical practice focuses on improving cardiac function primarily through exercise therapy. However, when they introduced oxygen therapy, specifically Hyperbaric Oxygen Therapy (HBOT), in combination with exercise, they observed significant benefits. By optimizing the use of the proper hyperbaric chamber, they achieved positive results in enhancing red blood cell production and supporting cardiac health. Dr. Mehta mentions research suggesting HBOT's potential in healing damage caused by heart attacks, encouraging individuals with low heart function to consider hyperbaric chamber treatment.

COVID-19 & Vaccine Injuries: The conversation shifts to the impact of HBOT on COVID-19 patients, especially those with severe inflammation and lung involvement. Dr. Mehta highlights that addressing inflammation is crucial in treating COVID-19 and emphasizes the importance of enhancing oxygen levels to alleviate inflammation. He contrasts the traditional approach of using immunosuppressants with the potential benefits of HBOT in increasing oxygen concentration and reducing inflammation, allowing the body to naturally combat the infection. The discussion also touches upon vaccine injuries and the growing concern about autoimmune disorders in vaccinated individuals.

Autism & Regenerative Medicine: The conversation transitions to autism, and Dr. Mehta shares insights into his clinic's experience with stem cell therapy for autism, specifically using Wharton's Jelly derived from umbilical cords. He explains the regenerative properties of Wharton's Jelly, which is rich in young stem cells capable of regenerating tissue. Despite witnessing significant improvements in brain function in autistic patients, regulatory changes led to limitations on the use of Wharton's Jelly for upper motor neuron disorders, including autism. Dr. Mehta expresses his willingness to continue using the therapy upon patient request if it doesn't harm the patient.

Back Pain & Regenerative Approaches: The discussion concludes with a focus on back pain, particularly sciatica and degenerative disc disease. Dr. Mehta outlines the challenges associated with traditional surgical approaches and highlights successful treatments for degenerative disc disease using intradiscal injections of bone marrow aspirate concentrate (BMAC). This regenerative method involves extracting stem cells from the patient's own bone marrow and injecting them intradiscally and into the surrounding areas. Positive outcomes, including pain relief and improved functionality, have been observed, offering a non-surgical alternative for certain patients. Dr. Mehta underscores the significance of regenerative medicine in providing effective solutions while reducing the overuse of surgery.

Throughout the conversation, Dr. Mehta emphasizes the potential benefits of HBOT and regenerative medicine in various medical conditions, supporting holistic and patient-centered approaches to healthcare.